Innate Pharma SA (IPHA) stock
IPHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as IPHYF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 0/30
$0.94−0.09 (-8.75%)
Close on Nov 19, 2026Market cap $88.09MP/E –Yield –
Innate Pharma shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 90M, up 10.5% from the year before. The highest annual figure on record is 90M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 90M | +10.5% |
| FY2024 | Dec 31, 2024 | 81M | +0.7% |
| FY2023 | Dec 31, 2023 | 80M | +1.0% |
| FY2022 | Dec 31, 2022 | 80M | +0.1% |
| FY2021 | Dec 31, 2021 | 80M | +0.8% |
| FY2020 | Dec 31, 2020 | 79M | +18.0% |
| FY2019 | Dec 31, 2019 | 67M | +13.8% |
| FY2018 | Dec 31, 2018 | 59M | +8.1% |
| FY2017 | Dec 31, 2017 | 54M | – |
See a number that looks wrong?